Larimar Therapeutics, Inc. (LRMR)
NASDAQ·Healthcare·Biotechnology
$2.39
+6.47%
Mkt Cap $251.40M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
Implied Upside
+235.4%
Consensus $8.00 vs current $2.39
NASDAQ·Healthcare·Biotechnology
$2.39
+6.47%
Mkt Cap $251.40M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$8.00
Range $5.00 – $11.00
+235.4%
Consensus $8.00 vs current $2.39